| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, Sulindac, Non-Steroidal Antiinflammatory Drugs;NF-kappaB (NFKB) Activation Inhibitors;ABCC3 Expression Enhancers;ABCC1 Expression Enhancers targeting PTGS2, TTR, ABCC3 (Novartis, 1548887) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/1548887 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the CB-86-ME74_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| GPX4 | glutathione peroxidase 4 | 0.595292 |
| RPLP2 | ribosomal protein, large, P2 | 0.386161 |
| THOC6 | THO complex 6 | 0.237734 |
| C19ORF33 | chromosome 19 open reading frame 33 | 0.210461 |
| Symbol | Name | Standardized Value |
|---|---|---|
| ZNF740 | zinc finger protein 740 | -0.210461 |